Biotech Startups

PACT develops earth-positive biomaterials for the fashion industry, scaling them up for supply to partner brands. The company runs a research and development laboratory and pilot facilities where scientists, engineers and designers create sustainable materials.

4 investors

Partillion generates cell-cell interaction data using Nanovials that co-localize cells in defined microenvironments to measure signaling, activation, binding, and other responses, with live-cell recovery via standard flow cytometry. Its platform serves researchers building biological models, discovering therapeutics such as T-cell engagers and antibodies, and profiling immune-target cell interactions.

4 investors

Paterna Biosciences develops in vitro spermatogenesis (IVS) technology that drives adult testicular stem cells to develop into optimized sperm, aiming to treat male infertility and improve IVF success rates. The company targets couples facing infertility and the broader male reproductive health field, where roughly half of failed IVF cycles involve a male factor.

4 investors

PerkinElmer is a scientific instrument and technology company that provides analytical tools and services for research, diagnostics, and life sciences applications. The company operates globally with a focus on enabling scientific discovery and sustainability.

4 investors

Phage Lab develops solutions to address bacterial outbreaks using a One Health approach, bringing together around 100 scientists and professionals from multiple disciplines in animal health and microbiology.

4 investors

Phagos develops phage therapy treatments as an alternative to antibiotics, using its Alphagos platform that combines microbiology and AI to design targeted bacterial medicines against antimicrobial resistance. Its treatments are deployed across animal agriculture sectors including chicken, cattle, swine, and shrimp.

4 investors

Phantom Neuro develops a minimally invasive, subcutaneous muscle-computer interface that uses under-the-skin sensors and on-device AI to translate muscle signals into control commands for robotic devices. Its initial application is prosthetic limb control for people with upper and lower limb difference, with future uses in robotics and human augmentation.

4 investors

Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema. It is a clinical-stage biopharmaceutical company focused on this rare disease area.

4 investors

PheroSyn develops and supplies pheromone-based insect monitoring and control products for farmers, using synthetic insect pheromones to target specific pests such as pea midge, pea leaf weevil, saddle gall midge, pear gall midge and wheat midge while reducing pesticide use. The company applies "Green Chemistry" techniques to agricultural pest management, with field trials conducted in the UK.

4 investors

PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.

4 investors

Phylo is an applied research lab studying agentic AI to accelerate biomedical discoveries for scientists. The company develops AI agents designed to advance how biomedical research is conducted.

4 investors

Picture Health develops AI tools that analyze routine radiology and pathology images to quantify biological properties of tumors for precision oncology. Its technology serves clinical development and translational science teams by producing imaging biomarkers from existing scans without additional tissue or lab tests.

4 investors

Pirouette develops OnePush, a fully automatic hidden-needle auto-injector platform paired with drug programs across chronic and rescue care indications. The company is advancing clinical-stage programs in naloxone, epinephrine, promethazine, and methotrexate while scaling U.S. automated manufacturing and securing IP protection through 2045.

4 investors

Plastomics develops trait delivery technology for agriculture using cell biology, plant tissue culture, transformation, and molecular biology methods. The company serves the agricultural industry with next-generation biotechnology solutions.

4 investors

PMV Pharma develops precision oncology therapies that target and structurally correct mutated p53 proteins to restore their tumor-suppressing function. The company focuses on treating cancers driven by p53 mutations.

4 investors

Prellis Biologics runs an antibody discovery platform that uses two-photon laser-bioprinted human immune organoids combined with machine learning to identify fully human antibody therapeutics. It develops a portfolio of antibody drug candidates across multiple disease areas and partners with biotech and pharmaceutical companies.

4 investors

Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units. The company's products are used to support nutrition and reduce complications in extremely premature infants globally.

4 investors

Promakhos Therapeutics develops immunomodulatory therapies to restore immune system balance and reduce chronic inflammation in diseases like Crohn's disease, ankylosing spondylitis, and psoriasis. The company targets patients with inflammatory diseases who do not benefit from current immunosuppressive treatments.

4 investors

Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery. The company operates in the medical device industry, serving pulmonologists and patients with severe emphysema through a minimally invasive lung treatment.

4 investors

PuraCath Medical develops disinfection technology for catheter connections designed to reduce infection risk in healthcare settings. The company targets healthcare providers and patients who use catheters.

4 investors

Qkine manufactures animal-free recombinant bioactive proteins, including growth factors, cytokines, biomarkers, and attachment factors, for stem cell, organoid, and cell culture research. Its products serve life science researchers in fields such as cellular agriculture, regenerative medicine, organ-on-a-chip, and bioprinting.

4 investors

Qualio provides a compliance platform for life science companies that combines quality management, regulatory intelligence, and AI agents to accelerate product delivery. The platform helps organizations optimize their quality and compliance systems.

4 investors

Quorum Bio develops genetic engineering tools for precision fermentation, enabling the production of complex natural products using engineered non-model microbes. The company targets the food, beverage, wellness, and agriculture industries with nature-based ingredients and biocontrols to replace synthetic chemicals.

4 investors

Quris develops a machine-learning platform for drug development, applying AI, engineering, and biology to predict how drugs will perform. The company works in the pharmaceutical and biotech space to improve how new drugs are tested and developed.

4 investors